We, Drug R&D (Research & Development) Expert, and PharmaDJ as well as Tigermed jointly held a Japan promotion session for Chinese pharmaceutical companies titled “From IND to NDA: How To Implement the Clinical Development Plan in Japan” at the first-day workshop of “ChinaTrials15” which was held in Shanghai, China on November 8th (Wed) to 10th (Fri), 2023.

In this session, Mr. Tetsuomi Takano, Editor-in-Chief, Drug R&D Expert as well as President and CEO, t2T Healthcare Inc., gave a presentation titled “An Overview of the Japanese Pharmaceutical Market and PMDAʼs Drug Regulations: From IND to NDA – How To Implement the Clinical Development Plan in Japan” and also participated in a panel discussion.